奥赛康 (002755)
BEIJING AOSAIKANG PHARMACEUTICAL CO.,LTD
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 92816.04
- Circulating A-Shares(W): 92815.16
- Earnings Per Share(RMB): 0.2400
- Net Assets Per Share(RMB): 3.4529
- Operating Revenue(W RMB): 143389.43
- Total Profit(W RMB): 21460.28
- Net Profit Attributable to Parent(W RMB): 22331.43
- Net Profit Growth Rate(%): 75.81
- Weighted Return on Equity(%): 7.1300
- Operating Cash Flow Per Share(RMB): 0.6480
- Undistributed Profit Per Share(RMB): 1.9957
- Capital Reserve Per Share(RMB): 0.1769
2. Main Business
The main business covers:
- Research, production, and sales of active pharmaceutical ingredients and preparations.
3. Company Basic Information
- Company Name: Beijing Aosaikang Pharmaceutical Co., Ltd.
- Listing Date: 2015-05-15
- Industry: Pharmaceutical Manufacturing
- Address: No. 699 Kejian Road, Jiangning Science Park, Nanjing, Jiangsu Province
- Website: www.ask-pharm.com
- Company Profile：The company was originally named Baoding New Star Petrochemical Engineering Co., Ltd., established through the overall restructuring of Baoding New Star Petrochemical Engineering Co., Ltd., with an initial total share capital of 31 million yuan. On December 5, 2007, the company was registered with the Baoding Administration for Industry and Commerce in Hebei Province, obtaining the "Business License of Enterprise Legal Person" with registration number 130605000003058. In July 2008, the company relocated to Fengtai Science Park, Zhongguancun National Independent Innovation Demonstration Zone in Beijing, and changed its name to "Beijing Oriental New Star Petrochemical Engineering Co., Ltd."
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Nanjing Aosaikang Investment Management Co., Ltd. | General Legal Person | 31747.06 | 34.20 |
| 2 | Zhongyi Weiye Holding Co., Ltd. | General Legal Person | 11822.18 | 12.74 |
| 3 | Jiangsu Suyang Investment Industrial Co., Ltd. | General Legal Person | 11721.41 | 12.63 |
| 4 | Weirui Development Co., Ltd. | General Legal Person | 11338.24 | 12.22 |
| 5 | Nanjing Haiji Investment Management Co., Ltd. | General Legal Person | 2724.57 | 2.94 |
| 6 | Yongying Pharmaceutical Innovation Selection Hybrid Initiated Securities Investment Fund Class A | Fund | 2095.25 | 2.26 |
| 7 | Yongying Ruixin Hybrid Securities Investment Fund Class A | Fund | 937.44 | 1.01 |
| 8 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 757.15 | 0.82 |
| 9 | Yongying Robust Enhancement Bond Securities Investment Fund Class A | Fund | 576.73 | 0.62 |
| 10 | E Fund Healthcare Industry Hybrid Securities Investment Fund Class A | Fund | 571.32 | 0.62 |
5. Concept Sectors
- Generic Drugs
- Helicobacter Pylori
- Innovative Drugs
- Margin Trading & Securities Lending
- Shareholder Reduction
- SME 300 Index
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information